Heptares Collaboration with AstraZeneca yields New Insights to Advance Drug Discovery in Pain, Cancer and Inflammation
Heptares Therapeutics , the wholly-owned subsidiary of Sosei Group Corporation , describes new insights for drug discovery from the first resolved high-resolution X-ray crystal...
Allergan Partners with TARGET PharmaSolutions to Advance NASH Research
Allergan, a leading global biopharmaceutical company, announced that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on real world evidence, on...
Roche to present new data at AAN reinforcing efficacy and safety of newly FDA-approved OCREVUS
Roche announced that new data on OCREVUS™ in people with relapsing forms of multiple sclerosis (RMS) and primary progressive MS (PPMS) will be presented...
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Allergan, a leading global biopharmaceutical company, announced today that it has entered into a clinical trial agreement with Novartis to conduct a Phase 2b...
Evoke Pharma and Spaulding Clinical Research Collaboration for the Exposure Pharmacokinetic Trial
Evoke Pharma, Inc. , a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases announced that the Company has reached an agreement to...
Valeo Pharma and Zambon form partnership for Parkinsons Disease Treatment Xadago
Zambon S.p.A., an international pharmaceutical company strongly committed to the central nervous system (CNS) therapeutic area, and Valeo Pharma Inc., a specialty pharmaceutical company...
Chugai’s phase III ALEX study comparing Alecensa and crizotinib meets primary endpoint
Chugai Pharmaceutical Co., Ltd. announced that Alecensa as an initial (first-line) treatment showed that patients lived significantly longer without disease worsening (progression-free survival, PFS)...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...